Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 4/2024

Edition 3/2024

Edition 2/2024

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Non-alcoholic fatty liver disease and risk of new-onset heart failure: An updated meta-analysis of about 11 million individuals

Gut. 2023;72(2):372–80

Positive hepatitis B core antibody is associated with advanced fibrosis and mortality in non-alcoholic fatty liver disease

Eur J Gastroenterol Hepatol. 2023;35(3):294–301

Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis

Lancet Gastroenterol Hepatol. 2023;8(1):20–30

Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH

J Hepatol. 2023;78(3):479–92

Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors

Clin Gastroenterol Hepatol. 2023;21(2):406–14.e7

Validation of the new 2021 EASL algorithm for the non-invasive diagnosis of advanced fibrosis in NAFLD

Hepatology. 2023;77(3):920–30

Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort

J Hepatol. 2023;78(3):501–12

Retreatment with immune checkpoint inhibitors after a severe immune-related hepatitis: Results from a prospective multicenter study

Clin Gastroenterol Hepatol. 2023;21(3):732–40

Pregnancy outcomes in women with autoimmune hepatitis - A nationwide population-based cohort study with histopathology

Clin Gastroenterol Hepatol. 2023;21(1):103–14.e10